The latest edition of Brainwaves, our biannual newsletter, is here! Discover the latest news, events, and research updates from the Brain Foundation and Migraine & Headache Australia. This edition also highlights the announcement of our 2024 Research Grant Awards. These innovative research projects inspire hope, paving the way for better treatments and cures for the brain diseases, disorders, and injuries that impact millions of Australians. If you missed our earlier posts highlighting each individual grant recipient, this is your chance to dive deeper into the groundbreaking work being carried out by researchers across the country. A heartfelt thank you to everyone who made these grants possible - whether through donations, raising awareness, hosting fundraisers, or supporting us in countless other ways. We hope you enjoy reading this edition of Brainwaves ➡️ https://lnkd.in/gbVq6gSU
Brain Foundation’s Post
More Relevant Posts
-
A new research study is using AI to improve life after stroke for stroke survivors! It's #BrainAwarenessWeek 🧠 and as part of the Stroke Alliance For Europe (SAFE) we're helping raise awareness of the importance of research in stroke. Today we are highlighting a new project called TRUSTroke TRUSTroke researchers are developing an advanced technology to help healthcare professionals, patients, and caregivers manage both short- and long-term effects of an ischemic stroke. Research is vital to enable more people than ever to survive stroke with better outcomes. Your donations have allowed us to give nearly half a million pounds to research to tackle these conditions. 👉 Read more about some of the stroke research we fund on our website at https://lnkd.in/eSdaRbAx
To view or add a comment, sign in
-
THE LONGEST DAY... Today, June 21st is the summer solstice and the longest day, and people from across the world will fight the darkness of Alzheimer's through a fundraising activity of their choice. Alzheimer's disease is a type of dementia that happens when an accumulation of proteins in the brain permanently damages brain tissues.This kind of brain damage eventually leads to symptoms like forgetfulness, loss of speech and writing abilities, and an inability to take care of yourself. As of 2023, over 6.7 million people over 65 years have received an Alzheimer's diagnosis, and an estimated 14 millionTrusted Source people may receive their diagnosis by 2060. Click the link to find out more about how you can help to raise funds and awareness for Alzheimer's... https://lnkd.in/eipTasQR
To view or add a comment, sign in
-
Hello friends, I’m reaching out today for a cause close to my heart. As the former Chair of Virginia's Alzheimer’s Disease and Related Disorders Commission, I spent nearly a decade advocating for those living with dementia and their caregivers. We achieved a lot, including the 2020-2024 Dementia State Plan, but there is still so much work ahead. With my 8-year term recently ending, I’ve rejoined the board of Richmond’s Alzheimer’s Association, and I’m asking for your support in this year’s walk—whether financially or by joining my team. Alzheimer’s isn’t just a statistic; it was my family’s reality. My mother began showing signs in her 40s and went undiagnosed for years. By her early 50s, she could no longer cook, drive, or remember our names. Alzheimer’s stole her independence, her memories, and ultimately, her life at just 57. It’s a brutal disease that leaves no survivors, taking loved ones piece by piece. Today, over 6 million Americans, including 150,000 Virginians, are living with Alzheimer’s. Every 65 seconds, someone in the U.S. develops the disease. Unlike cancer or heart disease, there is no cure. This year, I’ve launched Team White Flower, representing the hope for the first survivor of Alzheimer’s—a symbol of a future free from this devastating disease. I invite you to support our mission—join us, donate, or share our story. Together, we can raise awareness, fund critical research, and support families in need. Every contribution brings us closer to ending Alzheimer’s. Let’s walk for those we’ve lost, for those still fighting, and for a future without Alzheimer’s. https://lnkd.in/e--H4ZJt
To view or add a comment, sign in
-
Medical research is so important for everyone.
“We wanted to find a way to remember and honor Papa that was meaningful, purposeful and helped others just like he lived his life. The idea of a research grant in Papa's name was born. And the research grants are specifically for research into Parkinson's and dementia and neurodegenerative illnesses. And we thought that was a very fitting way to remember him, to have something meaningful, purposeful and a way of giving to others. We hope that the recipients of the research grants will be inspired, but Papa's life and his values, but also that they will go on in their own careers to replicate the standards of care that we received from Doctor Cordato.” - Giovanna Ferlaino, said of her late father Giuseppe. Help us continue the late Giuseppe Ferlaino's legacy. Support SSMRF’s medical research grants with a tax-deductible donation this EOFY and help us unlock hope for dementia research. 👉 Donate now https://lnkd.in/gVqRtd-u #UnlockHopeForDementiaResearch #ParkinsonsResearch #NeurodegenerativeResearch #EOFYDonation #MedicalResearch #SSMRFGrants #HonoringPapa
To view or add a comment, sign in
-
IBD is a lifelong disease, and there is no cure yet. CCA looks to the future by partnering with researchers to find a cure, while also seeking to provide practical, direct support to those currently living with IBD to manage the disease. We look forward to the day when there will be a cure for Crohn’s disease and ulcerative colitis. The research we fund looks to discover better treatments for those living with the disease and support earlier diagnosis, as well as conducting critical social and econometric research that helps to better advocate for improved care. Donate today and you are helping CCA to fund fellowships and research programs to help those living with IBD now and in the future. Pictured: Awareness Month Champion, Indiana.
To view or add a comment, sign in
-
I'm continuing my fight for a world without Alzheimer's. As part of my commitment, I serve on the 2024 Silicon Valley Walk to End Alzheimer's Executive Leadership Team. https://lnkd.in/gVtSPWJv Here are some facts about Alzheimer's: (1) Nearly 7 million Americans are living with Alzheimer's. (2) One in three seniors dies with Alzheimer's or another dementia. (3) Alzheimer's kills more than breast cancer and prostate cancer combined. (4) More than 11 million Americans provide unpaid care for people with Alzheimer's or other dementias. (5) In 2024, Alzheimer's and other dementias will cost the United States $360 billion. This number is projected to rise to nearly $1 trillion in 2050. If you are able, please help me raise money to help fight Alzheimer's and other dementia. Litherland, Kennedy & Associates will match any donations I receive and if you live in the Bay Area, you could also win lunch with me if you donate $100 or more.
Justin Kennedy's Walk to End Alzheimer's Page
act.alz.org
To view or add a comment, sign in
-
August 17th is International SLC6A1 Awareness day. A day for sharing knowledge, supporting research and raising funds! This year donations can go even further by sponsoring our Dragon Boat Race. We have a gift match offer that will match the funds raised! Donate or sponsor today, help cure children of this debilitating rare disease https://lnkd.in/eVDSdJ_Z What is #SLC6A1 ? It is a rare developmental and epileptic encephalopathy, or neurodeveloomental disorder. The gene slc6a1 has a mutation causing a loss of function. This means it cannot perform its job which is to code the GAT 1 protein, and transport GABA between neurons. GABA is a very important neurotransmitter, which means it send messages through brain cells. This faulty 'coding' causes a wide range if disabilities including #epilepsy #LearningDisabilities #neurodiversity #speechdelay #movementdisorder #challengingbehaviour #asd #adhd and reduced immunity. Children and adults can be non verbal, tube fed, and require 24 care, or they could be verbal, and able, but with some functional challenges. The spectrum is huge and the future unknown as the faulty gene was only discovered in 2015. Science being funded: Research cells and models available now Natural history study Biorepository Neuronal behaviour Absent seizures and slc6a1 Drug repurposing mRNA precision medicine AAV delivery Zebra fish models Global collaboration We might be rare, but we are MIGHTY, and your funds go a long way to support real work. Work that supports other rare DEEs and NDDs too.
Fundraiser - Space Quester Lindsay
peoplesfundraising.com
To view or add a comment, sign in
-
Such an inspiring project and such a powerful video! Medical research needs representation from people from a wide variety of backgrounds to help with funding prioritization, outcome evaluation, and key decision-making. There is a real imbalance of race, ethnicity, age and socio-economic status in research advocates and participants, and it can only change with your help. The poetry in this video explains why perfectly. I have the pleasure of being on the Scientific Advisory Council at Breakthrough T1D (JDRF) and their Insight and Experience Panel plays a key role in shaping the development of support services and innovative research projects. But that too needs more diversity. If you live with Type 1 Diabetes (or care for someone who does) please consider getting involved - https://lnkd.in/eRAQiV-m.
👉🏽 #INVISIBLE out now! A film exploring why we need more diverse voices involved in health research. Visit egality.health/be-visible Developed and produced by Egality Health, Freshrb C.I.C., lived experience partners, Research Black (researchblack.co.uk), Chronically Brown & spoken word by Duke Al (https://lnkd.in/ezzd2yZZ). Thank you to sponsor charities: Blood Cancer UK , Crohn's & Colitis UK, Diabetes UK, MS Society, Parkinson's UK, Versus Arthritis & the Charities Research Involvement Group! ❤️ #BeVisible
To view or add a comment, sign in
-
We are just a few short months away from our #Walk2EndAlz and I am thrilled to share that the Alzheimer’s Association Walk to End Alzheimer’s® – Phoenix, AZ is just around the corner on November 2, 2024. Are you as excited as we are? Join our GE Healthcare Rocky Mountain Phoenix Team and help us raise funds and Walk to End Alzheimer’s by clicking the link below: GE Healthcare Rocky Mtn Phx Team Page https://lnkd.in/g-giPKGn On November 2, GE Healthcare Phoenix will be participating in the Walk to End Alzheimer's, a vital event that raises funds and awareness to combat this devastating disease. Alzheimer’s disease affects more than 6 million Americans, with the numbers continuing to rise. It is the most common form of dementia, and its impact extends beyond the individual to families, caregivers, and entire communities. In Phoenix alone, many of our neighbors, friends, and colleagues are affected by Alzheimer’s, and we have the chance to make a difference in their lives. Here are some crucial facts about Alzheimer's disease: · Alzheimer’s is the 6th leading cause of death in the U.S. · Every 65 seconds, someone in the U.S. develops Alzheimer’s. · There are currently no treatments to slow or stop the progression of the disease. By participating in the Walk to End Alzheimer's, we can contribute to critical research efforts, support services for families, and raise awareness to drive change. Our involvement can help accelerate the search for a cure and provide hope to those affected. How You Can Get Involved: 1. Sign Up to Walk: Join us on November 2 at [Event Location] for a meaningful walk that brings our community together in the fight against Alzheimer’s. Register here: [Registration Link] 2. Make a Donation: Every contribution, big or small, helps fund research and support services. You can donate directly through our team page: [Donation Link] 3. Spread the Word: Share this event with friends and family to expand our support network and increase our impact.
GE HealthCare - Rocky Mtn Phoenix's Walk to End Alzheimer's Team Page
act.alz.org
To view or add a comment, sign in
-
Join the 2024 SRF Research Challenge to support research like Dr. Flynn's! Dr. Ryan Flynn (Harvard University, Boston Children's Hospital) shares information about his SRF-funded research project, Cell Surface GlycoRNAs in Autoimmunity, and how it could help people living with scleroderma. Your support of innovative research like Dr. Flynn's, and other projects funded by the SRF, helps advance our understanding of this disease. By joining this year's Research Challenge, you'll be a part of the next era of breakthroughs that could end scleroderma. Will you help us accelerate the pace of research so that we can one day end this disease? The best part is that when you make a gift to our Research Challenge, you’ll unlock a matching donation dollar-for-dollar*, thanks to the generosity of two families who, like you, are committed to finding a cure. Double your impact today: https://bit.ly/3RWrUOo P. S. Special thanks to our Research Challenge match donors—Board Members Luke Evnin (Chairman) and Deann Wright, and the Schimberg Family Foundation—for doubling the impact of your gift! *Up to $75,000 through July 31, 2024. #srfcure #sayscleroderma #sclerodermaresearch #scleroderma
Dr. Flynn Shares How His Research Could Help Those with Scleroderma
To view or add a comment, sign in
1,143 followers